Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore
Clinical trial NCT06202716 · UNKNOWN
Trial details
- NCT number
- NCT06202716
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2026-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.